Company Long-Term Loans and Borrowings: Tiziana Life Sciences PLC (TLSA)
This chart illustrates the market price and the long-term debt structure of Tiziana Life Sciences (TLSA), which currently stands at 0.00. A high probability of failure in new drug trials and the threat of liquidity shortages leave the company dependent on public market investments. The business is developing a nasal antibody delivery system to combat neuronal decay, utilizing closed scientific partnerships. Manufacturing processes and trials are outsourced to third-party contractors to minimize infrastructure costs.
Tiziana Life Sciences PLC (TLSA) - metric breakdowns and financial figures
- market price and analyst price targets:
- company stock exchange capitalization indicators:
- book capitalization information:
- debt level and financial liquidity data:
All Debt to Shareholders' Equity Ratio Tiziana Life Sciences|TLSA - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Tiziana Life Sciences, Ltd.|TLSA - Company Debts|Debt to Book Value Tiziana Life Sciences|TLSA - Company Long-Term Debt|Company Current Liabilities Tiziana Life Sciences|Quick Ratio tizianalifesciences.com
- earnings and multiples data:
Analysis of all company metrics:TLSA - tizianalifesciences.com
Investors must filter out market noise to objectively assess the issuer's credit risks. The development of nasal immunotherapy and foralumab trials require significant capital expenditures that determine financial stability. When analyzing the long-term loans and borrowings chart for Tiziana Life Sciences (TLSA), one should evaluate the total liabilities with a maturity exceeding one year. This price action reflects the balance between debt-financed innovation and the business's solvency.
Competitors of Tiziana Life Sciences (TLSA)
Company Long-Term Debts argenx.com ARGX|BNTX - Company Long-Term Debt|Company Long-Term Loans and Borrowings ABVX (abivax.com)|ADMA Bio (ADMA) - Company Long-Term Debt|Company Long-Term Liabilities Protagonist Corp|IMVT (Immunovant, Inc.) - Company Long-Term Debts|Company Long-Term Debts kiniksa.com|Company Long-Term Liabilities GRFS (Grifols)|ADPT (Adaptive Biotech) - Company Long-Term Loans and Borrowings|Company Long-Term Debts CLDX (Celldex)|Long-Term Debt Volume Aurinia Corp (AUPH)|BCRX - Company Long-Term Debt|veratx.com (VERA) - Company Long-Term Liabilities|Dianthus Therapeutics, Inc. (DNTH) - Company Long-Term Debt|Company Long-Term Liabilities Pharvaris NV|Company Long-Term Liabilities ABCL|Company Long-Term Debts Tourmaline|Company Long-Term Debt Precigen, Inc. (PGEN)|pharming.com - Company Long-Term Indebtedness|Company Long-Term Debts NKTR (Nektar Therapeutics Inc.)|Upstream Bio, Inc. (UPB) - Long-Term Debt|ZBIO: Company Long-Term Liabilities|Immunome Bio - Amount of Long-Term Liabilities|GOSS: Company Long-Term Debts|KALV - Long-Term Debt Volume|Company Long-Term Liabilities SEPN|Pieris Pharma - Long-Term Liabilities|Company Long-Term Debts SVRA|Long-Term Debt Volume Rigel Corp|Company Long-Term Debts ANAB (AnaptysBio, Inc.)|Company Long-Term Debts astriatx.com ATXS|ENGN - Company Long-Term Debt|RAPT (rapt.com) - Company Long-Term Indebtedness|JBIO: Company Long-Term Debts|Aclaris Therapeutics, Inc (ACRS) - Company Long-Term Debts|Company Long-Term Liabilities KYTX|CABA: Company Long-Term Loans and Borrowings|Company Long-Term Debt Ventyx Biosciences, Inc. (VTYX)|Company Long-Term Debt THTX (Theratechnologies, Inc.)|Company Long-Term Debts AVTX (Avalo Therapeutics Inc.)|Long-Term Debt Volume Eledon Pharmaceuticals, Inc (ELDN)|Agenus - Company Long-Term Debts|Long-Term Liabilities CLYM|ZURA: Company Long-Term Debts|Long-Term Debt aTyr Pharma Inc (ATYR)|Company Long-Term Liabilities ADAG|IMA: Company Long-Term Loans and Borrowings|Company Long-Term Debt Shattuck Labs, Inc. (STTK)|Long-Term Debt Volume equilliumbio.com|Company Long-Term Debts CNTB (Connect Biopharma Holdings Limited)|IMUX - Company Long-Term Liabilities|Atara Biotherapeutics Inc - Company Long-Term Debts|Long-Term Debt Volume InflaRx N.V. IFRX|XFOR: Company Long-Term Debts|Long-Term Debt Adicet Bio, Inc. (ACET)|Company Long-Term Debt Celularity Inc|Company Long-Term Indebtedness INMB (INmune Bio Inc)|Company Long-Term Debts BRNS|Company Long-Term Liabilities Kezar Life Sciences Inc KZR|Company Long-Term Debts SABS (SAB Biotherapeutics)|akaritx.com (AKTX) - Long-Term Debt|ENLV - Company Long-Term Debt|Long-Term Debt Volume Q32 Bio Inc. QTTB|GOVX (GeoVax Labs Inc) - Company Long-Term Liabilities|EDSA: Amount of Long-Term Liabilities|Company Long-Term Debt iBio, Inc.|Company Long-Term Debt CARM|Company Long-Term Debt XTL Biopharmaceuticals Ltd. (XTLB)|Long-Term Debt Volume boltbio.com|Company Long-Term Debts HCWB (HCW Biologics)|Company Long-Term Debts Aptevo Therapeutics, Inc. APVO|AIM - Company Long-Term Debt|Long-Term Liabilities ADTX|GRI: Company Long-Term Debts|XORTX Therapeutics Inc - Company Long-Term Loans and Borrowings|HIND (ReShape Lifesciences) - Company Long-Term Debts|Company Long-Term Debts Revelation Biosciences Corp|Company Long-Term Debt Indaptus Therapeutics (INDP)|SCNI (scinai.com) - Company Long-Term Loans and Borrowings|Company Long-Term Debt CalciMedica CALI|AFMD - Company Long-Term Liabilities|Allakos Therapeutics - Company Long-Term Debts|HOOK - Company Long-Term Debts|IGMS (igmbio.com) - Company Long-Term Liabilities|iteostherapeutics.com - Company Long-Term Loans and Borrowings|OCEA (Ocean Biomedical) - Company Long-Term Debts|TC BioPharm (Holdings) Plc (TCBP) - Long-Term Debt Volume|Company Long-Term Debt Third Harmonic Bio, Inc (THRD)